Database assessment of the effectiveness of brand versus generic rosiglitazone in patients with type 2 diabetes mellitus

Related articles

13 Dec 2018 : Animal Research

Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice

Yinzhi Cheng, Shuai Li, [...] Muzi Wang, Cheng Cheng, Rongyu Liu - Show fewer authors

DOI: 10.12659/MSM.910766

06 Sep 2018 : Laboratory Research

Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells

Xiao-xia Ji, Xiao-jing Ji, [...] Qian-qian Li, Xiao-xian Lu, Liang Luo - Show fewer authors

DOI: 10.12659/MSM.910036

01 Apr 2008

Rosiglitazone in the prevention of diabetes and cardiovascular disease: Dream or reality?

Tomas Stulc, Richard Ceska

01 Oct 2011

Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats

Fwu-Lin Yang, Yi-Maun Subeq, [...] Chung-Jen Lee, Ru-Ping Lee, Tai-Chu Peng, Horng-Jyh Harn, Bang-Gee Hsu - Show fewer authors

DOI: 10.12659/MSM.881975

02 Dec 2014 : Review article

Dulaglutide: A Review of a New Glucagon-Like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus

Mohamed Teleb, Ngamdu Sumayin, [...] Sarmad Said - Show fewer authors

DOI: 10.12659/MSRev.893152

07 Sep 2015 : Clinical Research

Genetic Variants of PTPN2 Gene in Chinese Children with Type 1 Diabetes Mellitus

Hui Peng, Jiamei Li, [...] Xiaoyun Chen, Xiao Zhou, Weiwei Zhu, Feng Li - Show fewer authors

DOI: 10.12659/MSM.893607

13 Feb 2016 : Clinical Research

Gene Polymorphism Association with Type 2 Diabetes and Related Gene-Gene and Gene-Environment Interactions in a Uyghur Population

Shan Xiao, Xiaoyun Zeng, [...] Yong Fan, Yinxia Su, Qi Ma, Jun Zhu, Hua Yao - Show fewer authors

DOI: 10.12659/MSM.895347

21 Jun 2011

Modulating gut microbiota as an anti-diabetic mechanism of berberine

Junling Han, Huiling Lin, [...] Weiping Huang - Show fewer authors

DOI: 10.12659/MSM.881842

19 Jun 2016 : Clinical Research

Building a Patient-Specific Risk Score with a Large Database of Discharge Summary Reports

Zhi Qu, Lue Ping Zhao, [...] Xiemin Ma, Siyan Zhan - Show fewer authors

DOI: 10.12659/MSM.899262

28 Jul 2016 : Animal Research

Exenatide Alters Gene Expression of Neural Cell Adhesion Molecule (NCAM), Intercellular Cell Adhesion Molecule (ICAM), and Vascular Cell Adhesion Molecule (VCAM) in the Hippocampus of Type 2 Diabetic Model Mice

Esen Gumuslu, Naci Cine, [...] Merve Ertan Gökbayrak, Oguz Mutlu, Ipek Komsuoglu Celikyurt, Guner Ulak - Show fewer authors

DOI: 10.12659/MSM.897401

30 Dec 2008

Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis

Krzysztof Celiński, Agnieszka Mądro, [...] Beata Prozorow-Król, Agnieszka Korolczuk, Halina Cichoż-Lach, Maria Słomka, Elżbieta Korobowicz - Show fewer authors

22 Dec 2005

The impact of rosiglitazone on cardiovascular responses and endurance during isometric exercise in patients with Type 2 Diabetes.

Jerrold Scott Petrofsky, Scott Lee

01 Dec 2005

The impact of rosiglitazone on heat tolerance in patients with Type 2 Diabetes.

Jerrold Petrofsky, Scott Lee, [...] Maria Cuneo-Libarona - Show fewer authors

01 Jun 2005 : Original article

Gait characteristics in patients with type 2 diabetes; improvement after administration of rosiglitazone

Jerrold S. Petrofsky, Scott Lee, [...] Maria L. Cuneo - Show fewer authors

01 Mar 2004

The metabolic effects of insulin and rosiglitazone combination therapy in Chinese Type 2 diabetic patients with nephropathy

Norman N. Chan, Peter C.Y. Tong, [...] Wing-Yee So, Wilson Y.S. Leung, Cherry K.P. Chiu, Juliana C.N. Chan - Show fewer authors